| Atypical hemolytic–uremic syndrome M Noris, G Remuzzi New England Journal of Medicine 361 (17), 1676-1687, 2009 | 1649 | 2009 |
| Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype M Noris, J Caprioli, E Bresin, C Mossali, G Pianetti, S Gamba, E Daina, ... Clinical Journal of the American Society of Nephrology 5 (10), 1844-1859, 2010 | 1308 | 2010 |
| Overview of complement activation and regulation M Noris, G Remuzzi Seminars in nephrology 33 (6), 479-492, 2013 | 1010 | 2013 |
| Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome J Caprioli, M Noris, S Brioschi, G Pianetti, F Castelletti, P Bettinaglio, ... Blood 108 (4), 1267-1279, 2006 | 911 | 2006 |
| Hemolytic uremic syndrome M Noris, G Remuzzi Journal of the American Society of Nephrology 16 (4), 1035-1050, 2005 | 777 | 2005 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 738 | 2017 |
| Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions M Noris, M Morigi, R Donadelli, S Aiello, M Foppolo, M Todeschini, ... Circulation research 76 (4), 536-543, 1995 | 731 | 1995 |
| Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura P Ruggenenti, M Noris, G Remuzzi Kidney international 60 (3), 831-846, 2001 | 726 | 2001 |
| Thrombomodulin mutations in atypical hemolytic–uremic syndrome M Delvaeye, M Noris, A De Vriese, CT Esmon, NL Esmon, G Ferrell, ... New England Journal of Medicine 361 (4), 345-357, 2009 | 665 | 2009 |
| Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells F Casiraghi, N Azzollini, P Cassis, B Imberti, M Morigi, D Cugini, ... The Journal of Immunology 181 (6), 3933-3946, 2008 | 563 | 2008 |
| STEC-HUS, atypical HUS and TTP are all diseases of complement activation M Noris, F Mescia, G Remuzzi Nature Reviews Nephrology 8 (11), 622-633, 2012 | 500 | 2012 |
| Mechanisms of disease: pre-eclampsia M Noris, N Perico, G Remuzzi Nature clinical practice Nephrology 1 (2), 98-114, 2005 | 490 | 2005 |
| Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype E Bresin, E Rurali, J Caprioli, P Sanchez-Corral, V Fremeaux-Bacchi, ... Journal of the American Society of Nephrology 24 (3), 475-486, 2013 | 431 | 2013 |
| Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ... The Journal of clinical investigation 111 (8), 1181-1190, 2003 | 407 | 2003 |
| The case of complement activation in COVID-19 multiorgan impact M Noris, A Benigni, G Remuzzi Kidney international 98 (2), 314-322, 2020 | 401 | 2020 |
| C3 glomerulopathy—understanding a rare complement-driven renal disease RJH Smith, GB Appel, AM Blom, HT Cook, VD D’Agati, F Fakhouri, ... Nature reviews nephrology 15 (3), 129-143, 2019 | 386 | 2019 |
| Familial haemolytic uraemic syndrome and an MCP mutation M Noris, S Brioschi, J Caprioli, M Todeschini, E Bresin, F Porrati, ... The Lancet 362 (9395), 1542-1547, 2003 | 379 | 2003 |
| Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility N Perico, F Casiraghi, M Introna, E Gotti, M Todeschini, RA Cavinato, ... Clinical Journal of the American Society of Nephrology 6 (2), 412-422, 2011 | 372 | 2011 |
| Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease J Caprioli, F Castelletti, S Bucchioni, P Bettinaglio, E Bresin, G Pianetti, ... Human molecular genetics 12 (24), 3385-3395, 2003 | 348 | 2003 |
| Dynamics of complement activation in aHUS and how to monitor eculizumab therapy M Noris, M Galbusera, S Gastoldi, P Macor, F Banterla, E Bresin, ... Blood, The Journal of the American Society of Hematology 124 (11), 1715-1726, 2014 | 345 | 2014 |
Benigni ArielaIstituto di Ricerche Farmacologiche Mario Negri Verificeret mail på marionegri.it
